ES512894A0 - "un procedimiento para obtener de orina una fraccion que contiene un ingrediente antineoplastico de naturaleza peptidica". - Google Patents

"un procedimiento para obtener de orina una fraccion que contiene un ingrediente antineoplastico de naturaleza peptidica".

Info

Publication number
ES512894A0
ES512894A0 ES512894A ES512894A ES512894A0 ES 512894 A0 ES512894 A0 ES 512894A0 ES 512894 A ES512894 A ES 512894A ES 512894 A ES512894 A ES 512894A ES 512894 A0 ES512894 A0 ES 512894A0
Authority
ES
Spain
Prior art keywords
antineoplastic
urine
ingredient
procedure
fraction containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES512894A
Other languages
English (en)
Other versions
ES8502417A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES8502417A1 publication Critical patent/ES8502417A1/es
Publication of ES512894A0 publication Critical patent/ES512894A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES512894A 1981-07-02 1982-06-07 "un procedimiento para obtener de orina una fraccion que contiene un ingrediente antineoplastico de naturaleza peptidica". Granted ES512894A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27972881A 1981-07-02 1981-07-02
US06/330,383 US4470970A (en) 1981-07-02 1981-12-15 Purified antineoplaston fractions and methods of treating neoplastic disease

Publications (2)

Publication Number Publication Date
ES8502417A1 ES8502417A1 (es) 1985-01-01
ES512894A0 true ES512894A0 (es) 1985-01-01

Family

ID=26959856

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512894A Granted ES512894A0 (es) 1981-07-02 1982-06-07 "un procedimiento para obtener de orina una fraccion que contiene un ingrediente antineoplastico de naturaleza peptidica".

Country Status (14)

Country Link
US (1) US4470970A (es)
EP (1) EP0069232B1 (es)
JP (3) JPH0729925B2 (es)
AU (1) AU551109B2 (es)
CA (1) CA1188218A (es)
DE (1) DE3273952D1 (es)
DK (2) DK162813C (es)
ES (1) ES512894A0 (es)
HK (1) HK30289A (es)
IL (1) IL65960A (es)
MY (1) MY102918A (es)
NO (1) NO163595C (es)
NZ (1) NZ200805A (es)
SG (1) SG4489G (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559325A (en) * 1981-12-15 1985-12-17 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4593038A (en) * 1985-04-03 1986-06-03 Burzynski Stanislaw R Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
US4705796A (en) * 1986-08-25 1987-11-10 Stereochemical Genetics, Inc. Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
WO1991016309A1 (en) * 1990-04-12 1991-10-31 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5089508A (en) * 1990-09-04 1992-02-18 Burzynski Stanislaw R Methods for treating aids
US5116622A (en) * 1990-09-12 1992-05-26 Burzynski Stanislaw R Methods for treating parkinson's disease
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US6037376A (en) * 1991-10-21 2000-03-14 The United States Of America As Represented By The Department Of Health And Human Services Methods for therapy of cancer
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
AU2804592A (en) * 1991-10-21 1993-05-21 Dvorit Samid Compositions and methods for therapy and prevention of cancer, aids, and anemia
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
US5783605A (en) * 1995-02-27 1998-07-21 Kuo; Sheng-Chu Helper inducers for differentiation therapy and chemoprevention of cancer
ATE310505T1 (de) * 1996-05-14 2005-12-15 Stanislaw R Burzynski Liposomale antineoplaston therapie mit bemerkenswert verbesserter antineoplastischer aktivität
EP1886677A1 (en) * 1996-07-26 2008-02-13 Susan P. Perrine Use of an inducing agent for the treatment of blood, viral and cellular disorders
US6258849B1 (en) 1998-07-23 2001-07-10 Stanislaw R. Burzynski Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
AU1553799A (en) * 1998-12-18 2000-07-12 Chang, Ming-Lieh Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof
US6987131B1 (en) 2000-06-26 2006-01-17 Burzynski Stanislaw R Phenylacetic acid compositions for treating or preventing hypercholesterolemia
MXPA05001267A (es) * 2002-08-01 2005-10-18 Aesgen Inc Tratamiento mejorado de cancer con glutamina.
US20060246016A1 (en) * 2003-05-28 2006-11-02 Burzynski Stanislaw R Toothpaste containing anticancer agents
US7087219B2 (en) * 2003-05-28 2006-08-08 Stanislaw R. Burzynski Toothpaste containing anticancer agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE463549A (es) *
GB2003887A (en) * 1977-09-06 1979-03-21 Nyegaard & Co As Isolation of peptides from urine
JPS57115330A (en) * 1981-01-08 1982-07-17 Toshiba Mach Co Ltd Forming process for thick plastic products and its metal mold
JP2897285B2 (ja) * 1989-10-19 1999-05-31 東洋紡績株式会社 熱可塑性樹脂フィルム積層物

Also Published As

Publication number Publication date
DE3273952D1 (en) 1986-12-04
MY102918A (en) 1993-03-31
DK143491A (da) 1991-08-06
NO163595C (no) 1990-06-27
DK162813B (da) 1991-12-16
JPH0729925B2 (ja) 1995-04-05
EP0069232A3 (en) 1984-07-04
IL65960A0 (en) 1982-09-30
NZ200805A (en) 1986-08-08
US4470970A (en) 1984-09-11
JPH0780764B2 (ja) 1995-08-30
EP0069232B1 (en) 1986-10-29
AU8423982A (en) 1983-01-06
EP0069232A2 (en) 1983-01-12
JPH0558886A (ja) 1993-03-09
CA1262907C (es) 1989-11-14
JPH0532548A (ja) 1993-02-09
ES8502417A1 (es) 1985-01-01
DK242082A (da) 1983-01-03
AU551109B2 (en) 1986-04-17
DK162813C (da) 1992-05-04
DK143491D0 (da) 1991-08-06
NO163595B (no) 1990-03-19
IL65960A (en) 1985-11-29
SG4489G (en) 1989-05-26
JPS5810521A (ja) 1983-01-21
JPH0739390B2 (ja) 1995-05-01
HK30289A (en) 1989-04-21
NO822218L (no) 1983-01-03
CA1188218A (en) 1985-06-04

Similar Documents

Publication Publication Date Title
ES512894A0 (es) "un procedimiento para obtener de orina una fraccion que contiene un ingrediente antineoplastico de naturaleza peptidica".
ES512882A0 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
ES514868A0 (es) "un procedimiento para la preparacion de un derivado de tiazol".
ES514750A0 (es) "procedimiento para la preparacion de n-fenil-sulfonil-n'-pirimidinil- y -triacinil-ureas".
ES512076A0 (es) "un procedimiento para la preparacion de piridin- y piracin-derivados".
ES515295A0 (es) "un procedimiento para la preparacion de imidazoquinazolinas".
ES514505A0 (es) "procedimiento para la preparacion de 1-amino-4-hidroxi-antraquinonas".
ES514109A0 (es) "un procedimiento para la preparacion de percarbonato sodico".
ES514572A0 (es) "un procedimiento para la preparacion de glutation".
ES510286A0 (es) "un procedimiento para la preparacion de nuevas fluoro-prostaciclinas".
ES514274A0 (es) "procedimiento para la preparacion de benzotriazoles".
ES513429A0 (es) "un procedimiento para la preparacion de una composicion nematocida".
ES514394A0 (es) "procedimiento para la preparacion de metil terci-butileter o etilterci-butileter".
ES514571A0 (es) "un procedimiento para la preparacion de glutation".
ES510928A0 (es) "un procedimiento para la preparacion de mercapto-acil-carnitinas".
ES512949A0 (es) "procedimiento para la preparacion de imidazolil-propionitrilos".
ES513832A0 (es) "un procedimiento para la preparacion de fenetilpiperidinas".
ES508723A0 (es) "un procedimiento para la preparacion de derivados de metoxicefalosporinas".
ES511252A0 (es) "procedimiento para la preparacion de prostaglandinas".
ES514106A0 (es) "procedimiento para la preparacion de hidrazonocefem-derivados".
ES514456A0 (es) "un procedimiento para la preparacion de esteres de 2-tenoilmercaptopropionilglicina".
ES512472A0 (es) Un procedimiento para la preparacion de 3(2-(3-alquil y alquenil-4-piperidil))indoles.
ES513723A0 (es) Un procedimiento para la preparacion de derivados de cistina".
ES511559A0 (es) "un procedimiento para la preparacion de (arimeltil) fenil-aminociclohexanos y -ciclohexenos".
ES515433A0 (es) "un procedimiento para la preparacion de una difenilamina".

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041004